Facebook
Instagram
Twitter
Vimeo
Youtube
Sign in
Business News
Top News
Money
Economy
Privacy Policy
Terms of Service
Disclaimer
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Business News
Top News
Money
Economy
Privacy Policy
Terms of Service
Disclaimer
Contact Us
Search
Home
Amgen bets on ChemoCentryx’s rare disease drug in $3.7 billion deal
FILE PHOTO: An Amgen sign is seen at the company’s
FILE PHOTO: An Amgen sign is seen at the company’s
FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo
- Advertisment -
Most Read
Eyeing China in the Pacific, US studies explosives to make missiles fly farther
August 3, 2023
For investors, green companies still hard to find with new emissions reporting rules
August 3, 2023
Pope, in Portugal to rally young Catholics, says Church needs purification
August 3, 2023
Wall Street ends down, investors step back after Fitch US rating cut
August 2, 2023
